FDA Inspection 1070713 — New York Reproductive Wellness Medicine, P.C.
The FDA completed an inspection of New York Reproductive Wellness Medicine, P.C. on Oct 5, 2018 in Melville, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 5, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Melville, NY (United States)